NASDAQ · Biotechnology
Iovance Biotherapeutics Inc (IOVA)
$6.90
-5.61%
31
In band
Moving averages
SMA 200$6.06+13.86%
Company profile
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. The company is headquartered in San Carlos, California.
SectorHealthcare
IndustryBiotechnology
Market cap$3.74B
P/E ratioNone
EPS$-0.49
Beta0.838
Dividend yield0.00%
52-week high$15.37
52-week low$2.08
Similar stocks in Biotechnology
BNTX
BioNTech SE
RSI 32
VRTX
Vertex Pharmaceuticals Inc
RSI 43
CRSP
CRISPR Therapeutics AG
RSI 27
IBRX
ImmunityBio Inc
RSI 40
TARS
Tarsus Pharmaceuticals Inc
RSI 54
VKTX
Viking Therapeutics Inc
RSI 44
ATAI
ATAI Life Sciences N.V.
RSI 62
RXRX
Recursion Pharmaceuticals Inc - Class A
RSI 34
AUPH
Aurinia Pharmaceuticals Inc
RSI 32
MRVI
Maravai LifeSciences Holdings Inc - Class A
RSI 48
RSI alerts for IOVA
An email when IOVA closes below RSI 30 or above 70. Nothing else.
Data last updated 13 November 2026 at 12:32 AM EST